CBF2 Antibody [mFluor Violet 450 SE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97347MFV450
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
mFluor Violet 450 SE (Excitation = 406 nm, Emission = 445 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Produced in rabbits immunized with E. coli-derived Human CBF2 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for CBF2 Antibody [mFluor Violet 450 SE]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CBF2
Alternate Names
CBF2CTF2, CBFHSP-CBF, CCAAT/enhancer binding protein (C/EBP), zeta, CCAAT/enhancer binding protein zeta, CCAAT/enhancer-binding protein zeta, CCAAT-binding factor, CCAAT-box-binding transcription factor, NOC1
Gene Symbol
CEBPZ
Additional CBF2 Products
Product Documents for CBF2 Antibody [mFluor Violet 450 SE]
Product Specific Notices for CBF2 Antibody [mFluor Violet 450 SE]
mFluor(TM) is a trademark of AAT Bioquest, Inc. This conjugate is made on demand. Actual recovery may vary from the stated volume of this product. The volume will be greater than or equal to the unit size stated on the datasheet.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...